Added to YB: 2025-06-11
Pitch date: 2025-06-08
HIMS [bullish]
Hims & Hers Health, Inc.
-64.46%
current return
Author Info
No bio for this author
Company Info
Hims & Hers Health, Inc. operates as a consumer-first health and wellness platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, Canada, Germany, the Republic of Ireland, France, Spain, and internationally.
Market Cap
$3.7B
Pitch Price
$57.21
Price Target
N/A
Dividend
N/A
EV/EBITDA
22.69
P/E
32.11
EV/Sales
1.83
Sector
Health Care Providers and Services
Category
growth
HIMS is really more than just an online drug company. Their next move is very interesting.
HIMS: Moving beyond DTC drugs to hormone health platform with TRT (20-25M US men market) & menopause care (50M US women) launching H2 2025. Strategy leverages existing customer base with online diagnosis & home delivery. At just 1% market penetration = $230M annual rev by 2030; 3-5% = $700M-$1.15B potential.
Read full article (2 min)